fruquintinib
hutchmed
['colorectal', 'fresco-2', 'rectal', 'fruquintinib', 'hutchmed']
hutchmed highlights phase iii fresco-2 mrct data summary of fruquintinib in refractory metastatic colorectal cancer from the upcoming esmo 2022 presentation #business
World News Guru is completely free and offers a broad range of media content from a varied and extensive range of sources.